Cafepharma Today

May 20 2025 - FDA outlines stricter Covid vaccine booster approval standards for healthy people
FDA outlines stricter Covid vaccine booster approval standards for healthy people
AHA warns tariffs could worsen drug shortages, pushes for long-term reform
Surveyed via text, HCPs say they want more interactions with pharma
Pfizer signs licensing deal worth about $6 billion with China's 3SBio for cancer drug
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer, Teva Accused in Suit of Keeping Generic Drug Off Market
Bloomberg
Friday, December 2, 2011 - 9:33am
tags:
Pfizer, Teva Pharmaceuticals, Effexor, generics, antidepressants
Drugmakers Go From Abundance To Scarcity
Pharmalot
Friday, December 2, 2011 - 9:32am
tags:
pharma industry
Athersys Shares Poised To Move Higher
Seeking Alpha
Friday, December 2, 2011 - 9:31am
tags:
Athersys, Pfizer, Mesoblast, Cephalon, Geron
Pain Management Stocks: Will This Painful Downturn End Soon?
Seeking Alpha
Thursday, December 1, 2011 - 5:09pm
tags:
pain management, Acura Pharmaceuticals, Cumberland, Durect Corporation, Endo, Horizon Pharma, Pacira, Pain Therapeutics, Zogenix
Something to Watch With Johnson & Johnson
Motley Fool
Thursday, December 1, 2011 - 5:08pm
tags:
JNJ
Emergent BioSolutions potential leukemia treatment receives 'orphan drug' status from FDA
Yahoo/AP
Thursday, December 1, 2011 - 12:56pm
tags:
FDA, orphan drugs, Emergent BioSolutions, leukemia, TRU-016, non-Hodgkin's lymphoma, chronic lymphocytic leukemia
CEO: Roche would consider more money-back deals
Fierce Pharma
Thursday, December 1, 2011 - 12:16pm
tags:
Avastin, Roche, Severin Schwan
Sucampo Pharma - Old Drugs, New Hopes
NASDAQ.com
Thursday, December 1, 2011 - 12:14pm
tags:
Sucampo, Rescula, glaucoma, Amitiza
[video] Spectrum Pharmaceuticals CEO: "We Are Always Looking for the Diamond in the Rough."
TheStreet.com
Thursday, December 1, 2011 - 12:12pm
tags:
Spectrum Pharmaceuticals, Zevalin
Why Large Cap Healthcare Multiples Should Expand
Seeking Alpha
Thursday, December 1, 2011 - 12:10pm
tags:
Abbott Laboratories, Gilead, JNJ, Merck, Medtronic, Medicis, Pfizer
Pfizer, GSK named in Onyx buyout gossip
Fierce Biotech
Thursday, December 1, 2011 - 11:48am
tags:
GSK, Pfizer, M&A, ONYX Pharmaceuticals
Health Care's 5 Worst November Flops
Motley Fool
Thursday, December 1, 2011 - 11:42am
tags:
Vertex, Seattle Genetics, Human Genome Sciences, Mako Surgical, Dendreon
Senators Probe Pfizer Plan To Block Generic Lipitor
Pharmalot
Thursday, December 1, 2011 - 11:28am
tags:
Senate, Pfizer, generics, Lipitor, PBMs
Mylan Sued by Warner Chilcott for Patent Infringement Over Generess FE
Bloomberg
Thursday, December 1, 2011 - 11:27am
tags:
Mylan, Warner Chilcott, patents, Generess FE, birth control pill
Drugmaker Pfizer completes acquisition of Ferrosan Consumer Health business
Yahoo/AP
Thursday, December 1, 2011 - 11:25am
tags:
Ferrosan, Pfizer, M&A, Europe
Pfizer Out Of Lipitor's Shadow, But Still Expects To Grow Profits
Seeking Alpha
Thursday, December 1, 2011 - 11:24am
tags:
Lipitor, generics, Pfizer
Takeda May Face 10,000 U.S. Suits Over Actos Cancer Claims
Bloomberg
Thursday, December 1, 2011 - 10:40am
tags:
Takeda, Actos, lawsuits, diabetes, bladder cancer
Ranbaxy launches Lipitor generic in U.S., shares surge
Yahoo/Reuters
Thursday, December 1, 2011 - 10:39am
tags:
Lipitor, generics, statins, Pfizer, Ranbaxy
Novartis MS Pill Gilenya Rejected by U.K. Health-Cost Agency
Bloomberg
Wednesday, November 30, 2011 - 7:42pm
tags:
Novartis, MS, multiple sclerosis, Gilenya
Savient Pharmaceuticals: Sluggish Launch Of Krystexxa Presents Buying Opportunity
Seeking Alpha
Wednesday, November 30, 2011 - 5:29pm
tags:
Krystexxa, Savient, gout

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.